Search

Your search keyword '"Larionova NV"' showing total 37 results

Search Constraints

Start Over You searched for: Author "Larionova NV" Remove constraint Author: "Larionova NV"
37 results on '"Larionova NV"'

Search Results

1. Study of Immunogenicity and Protective Efficacy of Live MDCK-derived Pandemic Influenza Vaccine

2. Value of N-terminal pro brain natriuretic peptide in predicting acute kidney injury in patients with acute decompensated chronic heart failure

3. Prognostic Significance of Erythropoietin in Patients With Acute Coronary Syndrome

5. Tritium content in vegetation cover at nuclear test locations at the "Sary-Uzen" site in the Semipalatinsk Test Site.

6. Peculiarities in accummulation of radionuclides by fruit and berry trees and shrubs.

7. Peculiarities of radioactive soil contamination in places of underground nuclear tests in the Semipalatinsk test site.

8. Characterization of area radioactive contamination of near-surface soil at the Sary-Uzen site in the Semipalatinsk test site.

9. Speciation of 137 Cs, 90 Sr, 241 Am, and 239+240 Pu artificial radionuclides in soils at the Semipalatinsk test site.

10. Transfer parameters of radionuclides from soil to plants at the area of craters produced by underground nuclear explosions at the Semipalatinsk test site.

11. Assessment of the tritium distribution in the vegetation cover in the areas of underground nuclear explosions at the Semipalatinsk test site.

12. Transfer of radionuclides to plants of natural ecosystems at the Semipalatinsk Test Site.

13. Distribution of artificial radionuclides in particle-size fractions of soil on fallout plumes of nuclear explosions.

14. Radionuclide transport in the "sediments - water - plants" system of the water bodies at the Semipalatinsk test site.

16. [Value of N-terminal pro brain natriuretic peptide in predicting acute kidney injury in patients with acute decompensated chronic heart failure].

17. [Prognostic Significance of Erythropoietin in Patients With Acute Coronary Syndrome].

18. [Endogenous erythropoietin, acute kidney injury, and prognosis in patients with acute coronary syndrome].

19. Accumulation of artificial radionuclides in agricultural plants in the area used for surface nuclear tests.

20. [Contribution of neuraminidase of influenza viruses to the sensitivity to the serum inhibitors and reassortment efficiency].

21. [Peculiarity of reassortment of current wild type influenza viruses with master donor viruses for live influenza vaccine].

22. Contamination mechanisms of air basin with tritium in venues of underground nuclear explosions at the former Semipalatinsk test site.

23. [Restriction analysis of genome composition of live influenza vaccine].

24. [Genome composition analysis of the reassortant influenza viruses used in seasonal and pandemic live attenuated influenza vaccine].

25. [Leading role of genes coding polymerase complex in attenuation of domestic donor viruses for A and B live influenza vaccine].

26. PB2 and PA genes control the expression of the temperature-sensitive phenotype of cold-adapted B/USSR/60/69 influenza master donor virus.

27. [Efficacy of production of reassortant of epidemic strains and cold-adapted influenza viruses in chicken embryo and MDCK cells].

28. [Live influenza vaccine: laboratory markers of attenuation].

29. [Phenotyte of epidemic influenza B virus strains isolated in different years].

30. [Genetic stability of cold-adapted influenza viruses].

31. [Genetic and phenotypic analysis of heterogeneous population of a cold-adapted donor of the A/Leningrad/134/17/57 (H2N2) attenuation and of the donor-based reassortant influenza vaccine strains].

32. A cyclopentane conformational restraint for a peptide nucleic acid: design, asymmetric synthesis, and improved binding affinity to DNA and RNA.

33. [The temperature sensitivity of epidemic influenza A viruses as a marker of immunogenicity of reassortant vaccinal strains].

34. Effect of membranotropic and mucoadhesive formulations of protein proteinase inhibitors on bovine herpes virus-1 reproduction.

35. Biodegradable cross-linked starch/protein microcapsules containing proteinase inhibitor for oral protein administration.

36. Preparation and characterization of microencapsulated proteinase inhibitor aprotinin.

37. [Experience with using autologous transfusion of ultraviolet- irradiated blood].

Catalog

Books, media, physical & digital resources